Async Distance Learning: September 25th, 2020 – September 24th, 2021
Live Webinar: October 8th – 9th, 2020

The need to modify format and time has turned Aibcc 2020 into a larger project that allows a better fruition and involvement. Two sessions are planned:

  • Async distance learning with main lectures that will be on-line from September 25th, 2020
  • 2 live webinars (October 8th and 9th) organized with Q&A and presentation of clinical cases.


Mortality from breast cancer is declining in most countries thanks to effective screening programs, early diagnosis, molecular characterization of the different subtypes and biology-driven treatments. A multidisciplinary management of breast cancer patients is therefore the key to success and a breast multidisciplinary team should include – besides the “classic” clinical specialties – pathologists, molecular biologists and geneticists. Furthermore, the availability of multiple diagnostic and therapeutic choices, the increasing costs of new technologies and drugs and the issue of sustainability represent a new challenge for socially-responsible clinicians.

With this goal in mind, the Programme includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes and issues of sustainability and drug access across countries.

Clinical case discussions and debates are planned to allow a continuous and fruitful exchange of experiences and opinions between speakers and participants.

In order to reward scientific excellence and to foster international cooperation, the International Scientific Committee of the 16th AIBCC will award the 10th International Prize for Breast Cancer Research to a scientist who has published a breakthrough paper in the previous year. We also welcome the presentation of posters from participants and the best poster will be awarded during the Award Ceremony.

The Conference is addressed to medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists who will have the opportunity to interact with breast cancer leaders and exchange experiences in a friendly atmosphere.

Addressed to

Gynaecologists and obstetrics, medical oncologists, pathologists, radiologists, radiation oncologists, surgeons. Biologists, pharmacists, and nurses.


Based on Italian regulations, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME:

  • Async Distance Learning: 9 CME points
  • Live Webinar: 6 CME points

Training objective: professional and technical content (knowledge and skills) specific to each profession, specialisation and highly specialised activity. Rare disease.

The credit certification is subject to:

  • Professions/specializations should correspond to those which have been accredited for CME
  • attendance at the 100% of the async distance learning and webinar live on the platform
  • the completion of the Meeting evaluation online form available at the end of each CME activity
  • completion of the final questionnaire (at least 75% of correct answers) at the end of each CME activity

We would like to remind you to participants that only 1/3 of CME credits can come from a sponsorship.

Official Language

The official language of the Meeting is English. No simultaneous translation will be provided.

University of Padua award for advances in breast cancer 2020

The Scientific Committee will select young researchers (< 40 years from any country) who have published in an international peer-reviewed journal, as the principal author, a manuscript reporting important clinical or biological advances in breast cancer. The winner will be invited to present his/her study during the annual Conference.

For further information: